🔗 Share this article

An underground market for unlicensed weight-loss drugs is being driven by TikTok fitness influencers and sellers on communication apps, according to new investigations.

Experimental Treatment Acquiring Traction Via Social Media

The experimental drug, which remains in research studies, is being promoted by social media influencers for its supposed fat-burning effects. Viewers are encouraged to contact these accounts directly for source information, while also receiving promotional offers.

Thriving Trade on Social Networks

Additionally, a flourishing market exists on Telegram, where communities with numerous of members share comparison photos, injection guides and claims of next-day UK delivery. Sellers promote the drug there before redirecting customers to other platforms for purchases.

Understanding The Experimental Drug

This medication is an investigational injectable created by American pharmaceutical company Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials suggest it could assist patients lose up to a quarter of their body weight. Referred to as the “triple G”, the substance is being hailed digitally as the successor to Ozempic.

Healthcare Experts Voice Worries

However, physicians and chemists have warned that the sale of what remains an unapproved drug in the United Kingdom is a cause for concern and could lead to users injecting substances of unknown origin.

Some experts stated the popularity for the experimental drug could be linked to the rising price of approved weight loss products such as Mounjaro.

Legal Status and Implementation

Selling retatrutide on social media or messaging apps is illegal in the United Kingdom, as it is an unlicensed drug that must not be promoted or distributed for human use under the Human Medicines Regulations 2012.

Several influencers attempt to circumvent the regulations by calling to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted drug, but promotion and supply can still breach pharmaceutical, advertising, and customer regulations, potentially leading to penalties, prosecution or imprisonment.

Service Reaction and Material Removal

Based on TikTok, the platform has taken down problematic content and banned associated hashtags and search suggestions. The organization said it was dedicated to keeping the platform secure and investing in enhancing enforcement strategies.

Online Trading Activities

Investigations also discovered communities with up to 9,000 members selling retatrutide using Telegram's integrated discovery tool, which operates like a online catalog. Entering “retatrutide” instantly displays channels with thousands of members, filled with photos of slimming results, positive reviews and step-by-step guides for mixing or administering at home.

After minutes of joining one group, a seller shared WhatsApp details, where the majority of transactions take place. The seller sent an guidebook and guaranteed shipping within 48 hours. When questioned whether the substance was genuine, one vendor said: “You can’t be sure.” Another shared a image of a supposed testing documentation. None inquired about body mass, health issues or previous experience.

Product Details and Costs

Inside these communities, messages show dark colored parcels with Royal Mail stickers, stating to contain fresh supplies. One communication read: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, prepared at residence with sterile water, or pre-filled injectors usually sold at 160 pounds for 20mg. When asked how much time a injector should be used, vendors give conflicting answers ranging from a several days to “depends on your body”.

Service Moderation and Safety Actions

A spokesperson for the messaging service stated it actively moderated dangerous content on its platform including material that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“Individuals are injecting substances they cannot confirm. Although the research behind retatrutide is valid, these online products may not include what they advertise,” said a pharmacy expert, the head of pharmaceutical services at Chemist4U.

A medical professional of Asda Online Doctor connected the surge in demand to recent price rises for approved slimming drugs such as Mounjaro. “With prices rising, patients are turning to online platforms. But counterfeit injections are highly risky. You can’t be certain what’s contained or whether the conditions they were produced in was sterile,” she explained.

Her team has already encountered patients injured by self-injection from unconfirmed suppliers. “We recognize the frustration, but purchasing from messaging apps or WhatsApp is taking chances with your health,” stated Wyllie. “These materials could be contaminated or incorrectly dosed.”

Producer Position

A representative from the pharmaceutical company stated retatrutide was in phase 3 clinical trials and had not been evaluated or approved by any government authority globally. “Consequently at this time no one can sell [it] for human use,” they explained, noting that any product “falsely representing itself as a company experimental product not yet approved … may subject users to possibly significant medical dangers”.